MELISSA DEVINCENTIS: Open Payments
NPI 1154967115 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 23 payments from 11 companies in 2025. Trend: 2023 $1,614 · 2024 $1,911 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $56 |
| Boston Scientific Corporation | 2 | $51 |
| PFIZER INC. | 2 | $45 |
| Amgen Inc. | 2 | $35 |
| HEARTFLOW, INC. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: JARDIANCE, VERQUVO, LifeVest, REPATHA, WATCHMAN FLX, FFRct, CAMZYOS, FARXIGA.
Industry payments across FL — which companies pay providers there.
